RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 163 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,222 | -40.1% | 1,131,826 | -28.4% | 0.00% | -33.3% |
| Q2 2023 | $2,040 | -21.9% | 1,581,126 | -20.1% | 0.00% | 0.0% |
| Q1 2023 | $2,612 | +118.0% | 1,978,718 | +147.8% | 0.00% | +50.0% |
| Q4 2022 | $1,198 | -99.9% | 798,500 | -38.8% | 0.00% | 0.0% |
| Q3 2022 | $1,540,000 | +273.8% | 1,305,226 | +258.1% | 0.00% | – |
| Q2 2022 | $412,000 | -36.3% | 364,500 | +68.4% | 0.00% | -100.0% |
| Q1 2022 | $647,000 | +237.0% | 216,400 | +198.1% | 0.00% | – |
| Q4 2021 | $192,000 | -74.5% | 72,600 | -67.1% | 0.00% | -100.0% |
| Q1 2021 | $754,000 | -89.7% | 220,500 | -89.4% | 0.00% | -87.5% |
| Q4 2020 | $7,310,000 | -9.9% | 2,088,614 | -38.2% | 0.01% | 0.0% |
| Q3 2020 | $8,113,000 | -23.8% | 3,380,414 | -41.9% | 0.01% | -11.1% |
| Q2 2020 | $10,646,000 | +62.1% | 5,817,683 | +38.2% | 0.01% | +50.0% |
| Q1 2020 | $6,566,000 | +3.1% | 4,209,123 | +41.4% | 0.01% | +20.0% |
| Q4 2019 | $6,371,000 | +79.8% | 2,976,940 | +57.1% | 0.01% | +66.7% |
| Q3 2019 | $3,543,000 | +939.0% | 1,894,638 | +1348.5% | 0.00% | – |
| Q2 2019 | $341,000 | -78.7% | 130,800 | -79.0% | 0.00% | -100.0% |
| Q1 2019 | $1,603,000 | -34.4% | 623,726 | -9.6% | 0.00% | 0.0% |
| Q2 2018 | $2,442,000 | 0.0% | 689,926 | 0.0% | 0.00% | -66.7% |
| Q1 2018 | $2,442,000 | -2.9% | 689,926 | +6.5% | 0.00% | 0.0% |
| Q4 2017 | $2,514,000 | +326.8% | 647,826 | +179.6% | 0.00% | +200.0% |
| Q3 2017 | $589,000 | -74.5% | 231,736 | -63.2% | 0.00% | -75.0% |
| Q3 2016 | $2,311,000 | +30.8% | 629,800 | -20.5% | 0.00% | +33.3% |
| Q2 2016 | $1,767,000 | +28.6% | 792,600 | +19.9% | 0.00% | 0.0% |
| Q1 2016 | $1,374,000 | -9.2% | 660,800 | +32.3% | 0.00% | 0.0% |
| Q4 2015 | $1,514,000 | +53.7% | 499,600 | +25.3% | 0.00% | +50.0% |
| Q3 2015 | $985,000 | +20.9% | 398,600 | +56.9% | 0.00% | 0.0% |
| Q2 2015 | $815,000 | +126.4% | 254,000 | +151.7% | 0.00% | +100.0% |
| Q1 2015 | $360,000 | -69.3% | 100,900 | -80.5% | 0.00% | -66.7% |
| Q4 2014 | $1,173,000 | +2.6% | 516,726 | -12.3% | 0.00% | 0.0% |
| Q3 2014 | $1,143,000 | -25.2% | 589,326 | +39.9% | 0.00% | -25.0% |
| Q2 2014 | $1,529,000 | +87.1% | 421,254 | +100.1% | 0.00% | +100.0% |
| Q1 2014 | $817,000 | -75.1% | 210,526 | -81.7% | 0.00% | -75.0% |
| Q4 2013 | $3,278,000 | +101.1% | 1,150,139 | +152.6% | 0.01% | +100.0% |
| Q3 2013 | $1,630,000 | +8.2% | 455,340 | +1.0% | 0.00% | 0.0% |
| Q2 2013 | $1,506,000 | – | 450,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |